BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Valproic acid
,
rs7903146
,
PPARA
,
Angiogenesis
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
trimer proteins
Summary
General Info
Curated Studies
Most Correlated Studies
Actomyosin contractility and its effect on tumor cell gene expression
Polysome bound or total RNA from neural stem cells after 48 hour of treatment with FAS ligand
Hepatoma Hepa 1-6 cells treated with TGFB1
Leukemia monocytic THP-1 cells treated with SARS-CoV-2 spike protein
Prostate stromal cells treated with Bleomycin and procyanidin C(PCC1)
Explore Curated Studies Results
Literature
Most Relevant Literature
First Principles Calculation of Protein-Protein Dimer Affinities of ALS-Associated SOD1 Mutants.
Microparticle immunocapture assay for quantitation of protein multimer amount and size.
A FlAsH reporter for protein-dimerization triggers.
MENSAdb: a thorough structural analysis of membrane protein dimers.
Investigating the stability of dengue virus envelope protein dimer using well-tempered metadynamics …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-20…
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malig…
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleura…
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascite…
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ